Proteome analysis of differential protein expression in cervical cancer cells after paclitaxel treatment.
about
Proteomic Analysis of Anticancer TCMs Targeted at MitochondriaPKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer.Proteomics approaches in cervical cancer: focus on the discovery of biomarkers for diagnosis and drug treatment monitoring.Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture.
P2860
Proteome analysis of differential protein expression in cervical cancer cells after paclitaxel treatment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Proteome analysis of different ...... ls after paclitaxel treatment.
@en
Proteome analysis of different ...... ls after paclitaxel treatment.
@nl
type
label
Proteome analysis of different ...... ls after paclitaxel treatment.
@en
Proteome analysis of different ...... ls after paclitaxel treatment.
@nl
prefLabel
Proteome analysis of different ...... ls after paclitaxel treatment.
@en
Proteome analysis of different ...... ls after paclitaxel treatment.
@nl
P2093
P2860
P1476
Proteome analysis of different ...... ls after paclitaxel treatment.
@en
P2093
Chan-Joo Kim
Eun-Kyoung Yim
Jong-Sup Park
Jun-Sang Bae
Keun-Ho Lee
Seung-Bak Lee
Soo-Jong Um
Sung-Eun Namkoong
P2860
P304
P356
10.4143/CRT.2004.36.6.395
P577
2004-12-31T00:00:00Z